Laura Vitale - Concepedia

Author

Laura Vitale

Celldex Therapeutics (United States)ORCID

Also Known As

L A Vitale, L Vitale, L. Vitale, Laura A Vitale, Laura A. Vitale, Laura Vitale, Thomas Davis, Vitale, Laura

142

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

Celldex Therapeutics (United States)University of Pennsylvania Memorial Sloan Kettering Cancer Center Providence Portland Medical Center Roswell Park Comprehensive Cancer Center

About

Laura Vitale is an author at Celldex Therapeutics (United States) specializing in immunology, medicine, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	20	1.2K
2	Engineering	2	2	79
3	Natural Sciences	1	1	37
4	Nursing	1	1	29
5	Public Health	1	1	29

Laura Vitale

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Induction of Antigen-Specific Immunity with a Vaccine Targeting NY-ESO-1 to the Dendritic Cell Receptor DEC-205 Madhav V. Dhodapkar, Mario Sznol, Biwei Zhao, Science Translational Medicine	2014	351
Phase I Study Utilizing a Novel Antigen-Presenting Cell–Targeted Vaccine with Toll-like Receptor Stimulation to Induce Immunity to Self-antigens in Cancer Patients Michael A. Morse, Robert Chapman, John D. Powderly, Clinical Cancer Research	2011	140
Antigenic Targeting of the Human Mannose Receptor Induces Tumor Immunity Li-Zhen He, Andrea Crocker, Janine Lee, The Journal of Immunology	2007	138
Activity and Safety of CTLA-4 Blockade Combined with Vaccines in Cynomolgus Macaques Tibor Keler, Ed Halk, Laura Vitale, The Journal of Immunology	2003	132
Finding a partner in the ocean: molecular and evolutionary bases of the response to sexual cues in a planktonic diatom Swaraj Basu, Shrikant Patil, Daniel Mapleson, New Phytologist	2017	131
Improved cellular and humoral immune responses in vivo following targeting of HIV Gag to dendritic cells within human anti–human DEC205 monoclonal antibody Cheolho Cheong, Jae‐Hoon Choi, Laura Vitale, Blood	2010	121
Antibody-Targeted NY-ESO-1 to Mannose Receptor or DEC-205 In Vitro Elicits Dual Human CD8+ and CD4+ T Cell Responses with Broad Antigen Specificity Takemasa Tsuji, Junko Matsuzaki, Marcus P. Kelly, The Journal of Immunology Cancer-testis AgImmunologyImmunoeditingAntigen ProcessingCd4 T Cell Responses	2010	116
Flt3 ligand augments immune responses to anti-DEC-205-NY-ESO-1 vaccine through expansion of dendritic cell subsets Nina Bhardwaj, Philip Friedlander, Anna C. Pavlick, Nature Cancer VaccinationDendritic Cell SubsetsAnti-dec-205-ny-eso-1 VaccineImmunologyTherapeutic Vaccine	2020	115
Mannose Receptor Targeting of Tumor Antigen pmel17 to Human Dendritic Cells Directs Anti-Melanoma T Cell Responses via Multiple HLA Molecules Venky Ramakrishna, Laura Vitale, John E. Connolly, The Journal of Immunology Dc Mannose ReceptorMannose Receptor TargetingImmunologyAntigen ProcessingCd4 T Cell Responses	2004	114
Agonist Anti-Human CD27 Monoclonal Antibody Induces T Cell Activation and Tumor Immunity in Human CD27–Transgenic Mice Li-Zhen He, Naseem Prostak, Lawrence J. Thomas, The Journal of Immunology Adaptive Immune SystemT-regulatory CellImmunologyImmunologic MechanismCd4 T Cell Responses	2013	101

Page 1